ChromaDex (NASDAQ: CDXC) reported Q2 EPS of ($0.09), $0.01 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $16.7 million versus the consensus estimate of $18.68 million.

For earnings history and earnings-related data on ChromaDex (CDXC) click here.